Szemészet, 2015 (152. évfolyam, 1-4. szám)

2015-12-01 / 4. szám

A szaruhártya gombás eredetű gyulladása

993-1000.

25. Knape R, Motamarry S, Sakhalkar M, Túli S, Driebe W. Pseudodendritic fungal epithelial keratitis in an extended wear contact lens user. Eye Contact Lens 2011; 37: 36-38

26. Krachmer J, Mannis M, Holland E; Cornea. In., 3ri edn: Elsevier; 2011.

27. Labbé A, Gabison E, Cochereau I, et al. Diagnosis of fungal keratitis by in vivo confocal microscopy: a case report. Eye (Lond) 2011; 25: 956-958.

28. Lalitha R Prajna N, Manoharan G, Srinivasan M, Mascarenhas J, Das M, D'Silva S, Porco T, Keenan J. Trends in bacterial and fungal keratitis in South India, 2002-2012. Br J Ophthalmol 2015; 99:192-194.

29. Larghi EL, Kaufman TS, Modulators of complement activation: A patent review (2008-2013). Expert Opinion on Therapeutic Patents 2014; 24: 665-686.

30. Matsumoto Y, Murat D, Kojima T, et al. The comparison of solitary topical micafungin or fluconazole application in the treatment of Candida fungal keratitis. Br J Ophthalmol 2011; 95: 1406-1409.

31. Mselle J. Fungal keratitis as an indicator of HIV infection in Africa. Trap Doct 1999; 29: 133-135.

32. Muslikhan Y, Yusof NS, Teo KSS, et al. Successful treatment of a refractory stromal fungal keratitis by intrastromal injection of amphotericin B. Int J Ophthalmol 2010; 10: 2054-2057.

33. Niederer RL, McGhee CNJ. Clinical in vivo confocal microscopy of the human cornea in health and disease. Progress in Retinal and Eye Research 2010; 29: 30-58.

34. Nielsen E, Heegaard S, Prause JU, et al. Fungal Keratitis - Improving Diagnostics by Confocal Microscopy. Case Rep Ophthalmol 2013; 4: 303-310.

35. Nielsen S, Nielsen E, Julian H, et al. incidence and clinical characteristics of fungal keratitis in a Danish population from 2000 to 2013. Acta Ophthalmol 2015; 93:

36. Prajna N, Krishnan T, Mascarenhas J, et al. Predictors of outcome in fungal keratitis. Eye 2012; 26: 1226-1231.

37. Prajna NV, John RK, Nirmalan PK, et al. A randomised clinical trial comparing 2% econazole and 5% natamycin for the treatment of fungal keratitis. Br J Ophthalmol 2003; 87: 1235-1237.

38. Prajna NV, Krishnan T, Mascarenhas J, et al, Mycotic Ulcer Treatment Trial G. The mycotic ulcer treatment trial: a randomized trial comparing natamycin vs voriconazole. JAMA ophthalmology 2013; 131: 422-429.

39. Reynolds MG, Alfonso E. Treatment of infectious scleritis and

keratoscleritis. Am J Ophthalmol 1991; 112: 543-547.

40. Sayin N, Kara N, Pekel G. Ocular complications of diabetes mellitus. World J Diabetes 2015; 6: 92-108.

41. Song X, Xie L, Tan X, et al: A multi-center cross-sectional study on the burden of infectious keratitis in China. In: PLoS One. vol. 9 (12), December 1, 2014 edn; 2014.

42. Srinivasan M. Fungal keratitis. Curr Opin Ophthalmol 2004; 15: 321-327.

43. Tabibian D, Richoz 0, Riat A, et al. Accelerated photoactivated Chromophore for keratitis-corneal collagen cross-linking as a first-line and sole treatment in early fungal keratitis. J Refractive Surg 2014; 30: 855-857.

44. Tayapad JB, Viguilla AQ, Reyes JM. Collagen cross-linking and corneal infections. Curr Opin Ophthalmol 2013; 24: 288-290.

45. Tayel SA, El-Nabarawi MA, Tadros Ml, et al. Promising ion-sensitive in situ ocular nanoemulsion gels of terbinafine hydrochloride: design, in vitro characterization and in vivo estimation of the ocular irritation and drug pharmacokinetics in the aqueous humor of rabbits. International journal of pharmaceutics 2013; 443: 293-305.

46. Thomas R Fungal infections of the cornea. Eye 2003; 17: 852-862.

47. Thomas R Kaliamurthy J. Mycotic keratitis: epidemiology, diagnosis and management. Clin Microbiol Infect 2013; 19: 210-220.

48. Thomas R Leek A, Myatt M. Characteristic clinical features as an aid to the diagnosis of suppurative keratitis caused by filamentous fungi. Br J Ophthalmol 2005; 89: 1554-1558.

49. Tuft S, Tullo A. Fungal keratitis in the United Kingdom 2003-2005. Eye 2009; 23: 1308-1313.

50. Uddaraju M, Mascarenhas J, Das MR, et al. Corneal cross-linking as an adjuvant therapy in the management of recalcitrant deep stromal fungal keratitis: A randomized trial. Am J Ophthalmol 2015; 160: 131-134.

51. Vemuganti G, Garg R Gopinathan U, et al. Evaluation of agent and host factors in progression of mycotic keratitis: A histologic and microbiologic study of 167 corneal buttons. Ophthalmology 2002; 109: 1538-1546.

52. Xie L, Dong X, Shi W. Treatment of fungal keratitis by penetrating keratoplasty. Br J Ophthalmol 2001; 85: 1070-1074.

53. Xie L, Shi W, Liu Z, et al. Lamellar keratoplasty for the treatment of fungal keratitis. Cornea 2002; 21: 33-37.

54. Zeng В, Wang R Xu LJ, et al. Amniotic membrane covering promotes healing of cornea epithelium and improves visual acuity after debridement for fungal keratitis. Int J Ophthalmol 2014; 7: 785-789.

Levelezési

cím

Dn Füst Ágnes, Semmelweis Egyetem, Szemészeti Klinika, 1085 Budapest, Mária u. 39. E-mail: fustagi@yahoo.com